Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.12 is 219% above its 5-year average of 0.98, around the middle of its 5-year range (0.00–8.87).
As of the fiscal period ended Wednesday, December 31, 2025. 21.35% above its 12-month average of 2.57.
Reported quarterly current ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 3.12.
CURRENT RATIO
3.12
CURRENT RATIO AVG TTM
2.57
CURRENT RATIO AVG 3Y
2.31
CURRENT RATIO AVG 5Y
0.98
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+21.35%
CURRENT VS 3Y AVG
+35.17%
CURRENT VS 5Y AVG
+219.19%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-17.02%
vs the sector median at left
NewGenIvf Group Limited
Market Cap
$6235.00
Current Ratio
3.12
TTM Avg
2.57
3Y Avg
2.31
5Y Avg
0.98
Market Cap
$29771.00
Current Ratio
4.22
TTM Avg
1.69
3Y Avg
2.61
5Y Avg
2.27
Market Cap
$70884.00
Current Ratio
5.07
TTM Avg
1.79
3Y Avg
4.80
5Y Avg
10.47
Market Cap
$95475.00
Current Ratio
8.09
TTM Avg
12.83
3Y Avg
6.46
5Y Avg
13.32
Market Cap
$110112.00
Current Ratio
0.94
TTM Avg
1.53
3Y Avg
2.70
5Y Avg
2.29
Market Cap
$378849.00
Current Ratio
9.97
TTM Avg
8.62
3Y Avg
13.45
5Y Avg
8.98
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NewGenIvf Group Limited (NIVF) | $6235.00 | 3.12 | 2.57 | 2.31 | 0.98 |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $29771.00 | 4.22 | 1.69 | 2.61 | 2.27 |
| Zhongchao Inc. (ZCMD)vs › | $30389.00 | 11.11 | 11.66 | 8.94 | 8.87 |
| Akanda Corp. (AKAN)vs › | $61172.00 | 0.22 | 0.98 | 0.64 | 0.52 |
| PRF Technologies Ltd. (PRFX)vs › | $70884.00 | 5.07 | 1.79 | 4.80 | 10.47 |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | 8.09 | 12.83 | 6.46 | 13.32 |
| Silexion Therapeutics Ltd. (SLXN)vs › | $110112.00 | 0.94 | 1.53 | 2.70 | 2.29 |
| SciSparc Ltd. (SPRC)vs › | $250443.00 | 2.41 | 3.89 | 3.24 | 3.47 |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | 9.97 | 8.62 | 13.45 | 8.98 |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | 0.78 | 0.50 | 0.69 | 2.39 |
Current Ratio
3.12
Quick Ratio
2.98
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2025-12-31 | 3.12 |
| 2025-09-30 | 3.43 |
| 2024-12-31 | 1.17 |
| 2024-09-30 | 0.28 |
| 2023-12-31 | 2.19 |
| 2023-09-30 | 8.87 |
| 2023-06-30 | 0.78 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.94 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
| 2021-09-30 | 0.16 |
| 2021-05-31 | 0.65 |
